Current Edition

Influence of Primary Components on Parenteral Delivery Systems, Biologic Therapies and Patient Outcome

The administration of parenteral biologics relies on interconnected attributes associated with compatibility of delivery components to the safety and efficacy of the final product. Diane Paskiet and Simon Côté of WestPharma address the importance of characterising individual components in contact with a biologic, to understand the risks to the delivery system as a whole and the effect on patient outcome. And selecting an appropriate delivery system for these therapies is critically important.